| Membrane transporters in drug development Nature reviews Drug discovery 9 (3), 215-236, 2010 | 3481 | 2010 |
| Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing MV Relling, EE Gardner, WJ Sandborn, K Schmiegelow, CH Pui, SW Yee, ... Clinical Pharmacology & Therapeutics 89 (3), 387-391, 2011 | 873 | 2011 |
| SLC transporters as therapeutic targets: emerging opportunities L Lin, SW Yee, RB Kim, KM Giacomini Nature reviews Drug discovery 14 (8), 543-560, 2015 | 778 | 2015 |
| Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin Y Chen, S Li, C Brown, S Cheatham, RA Castro, MK Leabman, TJ Urban, ... Pharmacogenetics and genomics 19 (7), 497-504, 2009 | 284 | 2009 |
| OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin L Chen, Y Shu, X Liang, EC Chen, SW Yee, AA Zur, S Li, L Xu, ... Proceedings of the National Academy of Sciences 111 (27), 9983-9988, 2014 | 226 | 2014 |
| Transporters in drug development: 2018 ITC recommendations for transporters of emerging clinical importance MJ Zamek‐Gliszczynski, ME Taub, PP Chothe, X Chu, KM Giacomini, ... Clinical Pharmacology & Therapeutics 104 (5), 890-899, 2018 | 212 | 2018 |
| The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin SL Stocker, KM Morrissey, SW Yee, RA Castro, L Xu, A Dahlin, ... Clinical Pharmacology & Therapeutics 93 (2), 186-194, 2013 | 211 | 2013 |
| Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin K Zhou, SW Yee, EL Seiser, N Van Leeuwen, R Tavendale, AJ Bennett, ... Nature genetics 48 (9), 1055-1059, 2016 | 197 | 2016 |
| The role of organic anion–transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics N Picard, SW Yee, JB Woillard, Y Lebranchu, Y Le Meur, KM Giacomini, ... Clinical Pharmacology & Therapeutics 87 (1), 100-108, 2010 | 188 | 2010 |
| International Transporter Consortium commentary on clinically important transporter polymorphisms KM Giacomini, PV Balimane, SK Cho, M Eadon, T Edeki, KM Hillgren, ... Clinical Pharmacology & Therapeutics 94 (1), 23-26, 2013 | 183 | 2013 |
| A Common 5′‐UTR Variant in MATE2‐K Is Associated With Poor Response to Metformin JH Choi, SW Yee, AH Ramirez, KM Morrissey, GH Jang, PJ Joski, ... Clinical Pharmacology & Therapeutics 90 (5), 674-684, 2011 | 166 | 2011 |
| Profiling solute carrier transporters in the human blood–brain barrier EG Geier, EC Chen, A Webb, AC Papp, SW Yee, W Sadee, KM Giacomini Clinical Pharmacology & Therapeutics 94 (6), 636-639, 2013 | 148 | 2013 |
| The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin‐Associated Musculoskeletal … RM Cooper‐DeHoff, M Niemi, LB Ramsey, JA Luzum, EK Tarkiainen, ... Clinical Pharmacology & Therapeutics 111 (5), 1007-1021, 2022 | 142 | 2022 |
| Comparison of human solute carriers A Schlessinger, P Matsson, JE Shima, U Pieper, SW Yee, L Kelly, ... Protein Science 19 (3), 412-428, 2010 | 136 | 2010 |
| Genome‐wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response CC Wen, SW Yee, X Liang, TJ Hoffmann, MN Kvale, Y Banda, ... Clinical Pharmacology & Therapeutics 97 (5), 518-525, 2015 | 130 | 2015 |
| Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function Y Chen, K Teranishi, S Li, SW Yee, S Hesselson, D Stryke, SJ Johns, ... The pharmacogenomics journal 9 (2), 127-136, 2009 | 123 | 2009 |
| A genome-wide association study of bronchodilator response in Latinos implicates rare variants KA Drake, DG Torgerson, CR Gignoux, JM Galanter, LA Roth, ... Journal of allergy and clinical immunology 133 (2), 370-378. e15, 2014 | 121 | 2014 |
| Organic anion transporter 2 (SLC22A7) is a facilitative transporter of cGMP CD Cropp, T Komori, JE Shima, TJ Urban, SW Yee, SS More, ... Molecular pharmacology 73 (4), 1151-1158, 2008 | 121 | 2008 |
| Influence of transporter polymorphisms on drug disposition and response: a perspective from the international transporter consortium SW Yee, DJ Brackman, EA Ennis, Y Sugiyama, LK Kamdem, R Blanchard, ... Clinical Pharmacology & Therapeutics 104 (5), 803-817, 2018 | 120 | 2018 |
| Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metformin EC Chen, X Liang, SW Yee, EG Geier, SL Stocker, L Chen, KM Giacomini Molecular pharmacology 88 (1), 75-83, 2015 | 113 | 2015 |
